COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria A case report

被引:9
作者
Sokol, Juraj [1 ]
Nehaj, Frantisek [2 ]
Mokan, Michal [2 ]
Lisa, Lenka [1 ]
Stasko, Jan [1 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Natl Ctr Hemostasis & Thrombosis, Dept Hematol & Transfus Med, Kollarova 2, Martin 03659, Slovakia
[2] Comenius Univ, Jessenius Fac Med Martin, Dept Internal Med 1, Martin 03659, Slovakia
关键词
case report; complement; COVID19; paroxysmal nocturnal hemoglobinuria; treatment; thrombosis;
D O I
10.1097/MD.0000000000025456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, life-threatening hemopoietic stem cell disorder characterized by the triad of hemolytic anemia, thrombosis, and impaired bone marrow function. Evidence suggests that severe outcomes in COVID19 infection are attributed to the excessive activation of the complement cascade leading to acute lung injury and associated is with an increased prothrombotic state. Patient concerns: A 27-year-old Caucasian man with PNH presented to the Emergency Department of our hospital with acute onset shortness of breath, cough and blood in urine. Diagnosis: The patient was diagnosed with acute hemolytic exacerbation of PNH complicated with moderate COVID19 pneumonia. Outcomes: The patient was initiated with an anticoagulant unfractionated heparin, dexamethasone, and cefuroxime injection. His symptoms quickly resolved, and he was discharged after 5 days. Conclusion: The complement system activation is a critical component in the sequalae of COVID19 infection. Evidence suggests that severe outcomes in COVID19 infection are attributed to the excessive activation of the complement cascade leading to acute lung injury and associated is with an increased prothrombotic state. Notably, C5a concentration was noted to be higher in patients with COVID19 infection. The use of complement inhibitors to attenuate immune mediated damage in COVID19 nevertheless represents a very interesting theoretical approach. However, careful consideration as to which patients may benefit will be required and the outcome of clinical trials needed.
引用
收藏
页数:4
相关论文
共 19 条
  • [1] Alencar Railene Célia B., 2016, J. Bras. Patol. Med. Lab., V52, P307, DOI 10.5935/1676-2444.20160051
  • [2] Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders
    Araten, David J.
    Belmont, H. Michael
    Schaefer-Cutillo, Julia
    Iyengar, Arjun
    Mattoo, Aprajita
    Reddy, Ramachandra
    [J]. AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 4
  • [3] Complement Activation during Critical Illness: Current Findings and an Outlook in the Era of COVID-19
    Bosmann, Markus
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (02) : 163 - 165
  • [4] Therapeutic challenges in pregnant women with paroxysmal nocturnal hemoglobinuria A case report
    Coelho Bastos, Juliana Marques
    Pinheiro, Patricia Leal
    Rocha, Lissa Canedo
    Bicalho, Elisa Cao
    Cazeli, Alessandra Barbosa
    Marcondes, Sibia Soraya
    Pinasco, Gustavo Carreiro
    [J]. MEDICINE, 2018, 97 (36)
  • [5] de Brito LC., 2011, Rev Bras Hematol Hemoter, V33, P35
  • [6] Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review
    Devalet, Berangere
    Mullier, Francois
    Chatelain, Bernard
    Dogne, Jean-Michel
    Chatelain, Christian
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) : 190 - 198
  • [7] Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review
    Fletcher-Sandersjoo, Alexander
    Bellander, Bo-Michael
    [J]. THROMBOSIS RESEARCH, 2020, 194 : 36 - 41
  • [8] Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion
    Gembillo, Guido
    Siligato, Rossella
    Cernaro, Valeria
    Santoro, Domenico
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [9] Genthon A., 2021, LEUKEMIA LYMPHOMA, V8, P1
  • [10] Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
    Hoechsmann, Britta
    Rojewski, Markus
    Schrezenmeier, Hubert
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (08) : 887 - 899